Deficient Emotional Self-Regulation (DESR) Completed Phase 4 Trials for Omega-3 fatty acids (DB11133)

Also known as: Deficient Emotional Self-Regulation

Indication	Status	Phase
DBCOND0053321 (Deficient Emotional Self-Regulation (DESR))	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02204410	Omega-3 Supplementation to ADHD Medication in Children	Treatment	Amphetamine (DB00182) Dexmethylphenidate (DB06701) Dextroamphetamine (DB01576) Guanfacine (DB01018) Lisdexamfetamine (DB01255) Methylphenidate (DB00422) Omega-3 fatty acids (DB11133)